Evaluation of adolescents for polycystic ovary syndrome in an urban population

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 1, Issue 4, 2009, Pages 188-193

  Broder Fingert, Sarabeth ^a   Shah, Bina ^a   Kessler, Marion ^a   Pawelczak, Melissa ^a   David, Raphael ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent; Morbidity; PCOS; Polycystic ovary syndrome

Indexed keywords

ACNE; ADOLESCENT; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATIENT REFERRAL; RETROSPECTIVE STUDY; UNITED STATES; URBAN POPULATION;

ADOLESCENT; FEMALE; HIRSUTISM; HUMANS; MENSTRUATION DISTURBANCES; NEW YORK CITY; OUTPATIENT CLINICS, HOSPITAL; OVARIAN DISEASES; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; URBAN POPULATION; YOUNG ADULT;

EID: 77953472920     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4008/jcrpe.v1i4.50     Document Type: Article

References (18)

1. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357-1363.
2. Hassan A, Gordon CM. Polycystic ovary syndrome update in adolescence. Current Opinion in Pediatrics 2007;19:389-397.
3. Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends in Edocrinology and Metabolism 2007;18:266-272.
4. Kousta E, Tolis G, Franks S. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens) 2005;4:133-147.
5. Hahn S, Tan S, Sack S, et al. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2007;115:130-135.
6. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935.
7. Goodarzi MO, Azziz R. Diagnosis, epidemiology and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:193-205.
8. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
9. Arslanian SA, Witchel SF. Polycystic ovary syndrome in adolescents: is there an epidemic? Current Opinion in Endocrinology & Diabetes 2002;9:32-42.
10. Coveillo AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492-497.
11. Salmi DJ, Zisser HC, Jovanovic L. Screening for and Treatment of Polycystic Ovary Syndrome in Teenagers. Experimental Biology and Medicine 2004;229:369-377.
12. American Academy of Pediatrics, Committee on Adolescence, American College of Obstetricians and Gynecologists and Committee on Adolescent Health Care. Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Pediatrics 2006;118:2245-2250.
13. Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004;62:278-282.
14. Guttmann-Bauman I. Approach to Adolescent Polycystic Ovary Syndrome (PCOS) in the Pediatric Endocrine community in the USA. J Pediatr Endocrinol Metab 2005;18: 499-506.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
16. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
17. Coviella AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492-497.
18. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005; 62:289-295.